Xeris Biopharma Quote - XERS

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

3.16

Bid

3.15

Offer

3.34

Volume

2,439,595

3.15 Day's Range 3.325

1.46 52 Week Range 3.64

Market Cap

470.836M

Previous Close

3.15

Open

3.20

Last Trade

3.16

Last Trade Time

Financial Volume

US$ 7,849,820

VWAP

3.2177

Average Volume (3m)

1,604,931

Shares Outstanding

148,998,825

Dividend Yield

PE Ratio

-7.54

Earnings Per Share (EPS)

-0.42

Revenue

163.91M

Net Profit

-62.26M

Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies in Illinois. The company markets Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalem... Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies in Illinois. The company markets Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect. The company was incorporated in 2005 and is headquartered in Chicago, Illinois. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.xerispharma.com

Headquarters

Wilmington, Delaware, USA

Founded

Xeris Biopharma Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker XERS. The last closing price for Xeris Biopharma was US$3.15. Over the last year, Xeris Biopharma shares have traded in a share price range of US$ 1.46 to US$ 3.64.

Xeris Biopharma currently has 148,998,825 shares in issue. The market capitalisation of Xeris Biopharma is US$469.35 million. Xeris Biopharma has a price to earnings ratio (PE ratio) of -7.54.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.15	-4.53172205438	3.31	3.64	3.025	3527555	3.3443214	CS
4	0.11	3.60655737705	3.05	3.64	2.962669	1792725	3.25695601	CS
12	0.45	16.6051660517	2.71	3.64	2.48	1604931	2.97948755	CS
26	1.35	74.5856353591	1.81	3.64	1.77	1508354	2.63211045	CS
52	1.49	89.2215568862	1.67	3.64	1.46	1716873	2.47411428	CS
156	0.8	33.8983050847	2.36	3.64	0.9701	1529560	2.25490338	CS
260	-4.91	-60.8426270136	8.07	10.5	0.9701	1790519	3.08014165	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MVSTMicrovast Holdings Inc	US$ 0.7951 (340.01%)	1.08B
QUBTQuantum Computing Inc	US$ 2.66 (92.75%)	102.15M
PULMPulmatrix Inc	US$ 3.56 (73.66%)	3.63M
BTCTBTC Digital Ltd	US$ 17.65 (68.10%)	45.02M
NMHINatures Miracle Holding Inc	US$ 0.142 (65.69%)	1.33B
SYRSSyros Pharmaceuticals Inc	US$ 0.359 (-86.85%)	37.89M
GCTKGlucoTrack Inc	US$ 0.36 (-77.06%)	6.42M
PETWag Group Company	US$ 0.21 (-67.98%)	14.63M
GLXGGalaxy Payroll Group Ltd	US$ 6.24 (-56.39%)	2.96M
XFORX4 Pharmaceuticals Inc	US$ 0.2773 (-53.17%)	18.49M
NMHINatures Miracle Holding Inc	US$ 0.142 (65.69%)	1.33B
MVSTMicrovast Holdings Inc	US$ 0.7951 (340.01%)	1.08B
ELABElevai Labs Inc	US$ 0.0247 (31.38%)	540.25M
AGRIAgriFORCE Growing Systems Ltd	US$ 0.0486 (2.53%)	288.52M
NVDANVIDIA Corporation	US$ 146.27 (-1.36%)	188.11M